top of page
 |  |  |  |  |
|---|---|---|---|---|
 |
Breast cancer is the most common female malignancy in Nigeria with an incidence rate of about 54.3/100,000.This rate is steadily on the rise and is associated with increased mortality.
Among Nigerian women, breast cancer is diagnosed at a younger age and later stage (>80% with stage III/IV), a higher proportion of tumors are triple negative (~40%), and both overall and stage-specific survival is worse than in high-income countries.
Principal Investigators
The ActioN study is led by Dr. Tulin Cil & Dr Funmilola Wuraola
Principal Investigator
Dr. Tulin Cil
Breast Surgeon (MD, MEd, FRCS(C), FACS)
Gattuso Chair in Breast Surgical Oncology
University Health Network, Princess Margaret Cancer Centre
Associate Professor, Department of Surgery, University of Toronto
Co-Principal Investigator
Dr. Funmilola Wuraola
Consultant Breast Surgeon (MBBS, ChM, FWACS)
Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria
General Surgical Oncology Prakash Fellow ,University of Toronto in Breast Surgical Oncology
bottom of page